Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07660796 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 35 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
Trial Details
NCT Number NCT07660796
Lead Sponsor Hanmi Pharmaceutical Company Limited
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 256 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov